Akiko Uchida, Yasushi Isobe, Junko Asano, Yu Uemura, Masahiro Hoshikawa, Masayuki Takagi, Ikuo Miura. Targeting BCL2 with venetoclax is a promising therapeutic strategy for “double-proteinexpression” lymphoma with MYC and BCL2 rearrangements. haematol [Internet]. 2019Jun.30 [cited 2024Nov.24];104(7):1417-21. Available from: https://haematologica.org/article/view/8972